The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Division of Neonatology, Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Pediatr Pulmonol. 2021 Jun;56(6):1771-1778. doi: 10.1002/ppul.25324. Epub 2021 Mar 3.
Iron deficiency during early life could affect the developing lung and immune system, and influence child's respiratory or allergy outcomes in later life.
To examine the associations of maternal iron status during early pregnancy with child's lung function, asthma, inhalant allergic sensitization, and physician-diagnosed inhalant allergy at school-age.
In a population-based cohort study, among 3825 mother-child pairs, ferritin, transferrin concentrations, and transferrin saturation were measured from maternal venous blood samples during early pregnancy. In children at the age of 10 years, spirometry was used to determine child's lung function, current asthma and physician-diagnosed inhalant allergy were assessed by questionnaires, and inhalant allergic sensitization was measured by skin prick tests. We used multivariable regression models to examine the associations.
After adjustment for gestational age at maternal iron status measurement and sociodemographic or lifestyle-related confounders, a higher maternal transferrin concentration was associated with a higher risk of physician-diagnosed inhalant allergy (odds ratio [95% confidence interval]: 1.13 [1.01 to1.26]), but not with lung function, asthma, or inhalant allergic sensitization. This association did not attenuate after further adjustment for maternal hemoglobin levels or early growth factors. We observed no consistent association of maternal ferritin concentrations or transferrin saturation with child's respiratory or allergy outcomes.
Higher maternal transferrin concentrations during pregnancy, reflecting lower serum iron levels, were associated with an increased risk of child's physician-diagnosed inhalant allergy but not lung outcomes. Underlying mechanisms and clinical implications need to be explored.
生命早期的缺铁可能会影响肺部和免疫系统的发育,并影响儿童在以后生活中的呼吸或过敏结局。
研究妊娠早期母亲铁状况与儿童肺功能、哮喘、吸入性变应原致敏以及学龄期医生诊断的吸入性变应原的关系。
在一项基于人群的队列研究中,在 3825 对母子中,在妊娠早期从母亲静脉血样中测量了铁蛋白、转铁蛋白浓度和转铁蛋白饱和度。在 10 岁儿童中,使用肺量计测定儿童的肺功能,通过问卷调查评估当前哮喘和医生诊断的吸入性变应原,通过皮肤点刺试验测定吸入性变应原致敏情况。我们使用多变量回归模型来研究相关性。
在校正了母亲铁状况测量时的胎龄以及社会人口统计学或生活方式相关混杂因素后,较高的母体转铁蛋白浓度与医生诊断的吸入性变应原的风险增加相关(比值比[95%置信区间]:1.13[1.01 至 1.26]),但与肺功能、哮喘或吸入性变应原致敏无关。在进一步校正母体血红蛋白水平或早期生长因子后,这种关联没有减弱。我们没有观察到母体铁蛋白浓度或转铁蛋白饱和度与儿童呼吸或过敏结局的一致关联。
妊娠期间母体转铁蛋白浓度升高,反映了血清铁水平较低,与儿童医生诊断的吸入性变应原过敏风险增加有关,但与肺功能结果无关。需要进一步探讨其潜在机制和临床意义。